Corcept Therapeutics Inc (CORT)
51.43
+0.28
(+0.55%)
USD |
NASDAQ |
Dec 20, 16:00
51.46
+0.03
(+0.06%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly): 25.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics Inc | 29.96% |
| Catalyst Pharmaceuticals Inc | 34.10% |
| Madrigal Pharmaceuticals Inc | -172.0% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Ionis Pharmaceuticals Inc | -105.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 25.77% |
| Return on Assets | 21.04% |
| Return on Invested Capital | 25.77% |
| Gross Profit Margin (Quarterly) | 98.43% |
| Operating Margin (Quarterly) | 25.53% |
| Return on Net Operating Assets | 199.0% |